During the past decade, SSZZOZ im. dr Teodora Dunina w Rudce conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SSZZOZ im. dr Teodora Dunina w Rudce" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SSZZOZ im. dr Teodora Dunina w Rudce" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "First Line Non-Small Cell Lung Cancer" (1 trials) and "Metapneumovirus" (1 trials). Many other conditions were trialed in "SSZZOZ im. dr Teodora Dunina w Rudce" in a lesser frequency.

Most popular intervention types in "SSZZOZ im. dr Teodora Dunina w Rudce" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (2 trials), "Avelumab Weekly" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "SSZZOZ im. dr Teodora Dunina w Rudce" are 3 trials for "All" genders.

Currently, there are NaN active trials in "SSZZOZ im. dr Teodora Dunina w Rudce". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SSZZOZ im. dr Teodora Dunina w Rudce, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SSZZOZ im. dr Teodora Dunina w Rudce, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".